Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HairDays has developed a digital health platform that uses proprietary algorithms and big data to analyze individual hair profiles. The system provides personalized recommendations for products and care regimens to improve hair and scalp health. The company has received a Phase I SBIR grant from the National Science Foundation for its data-driven approach[2]. Its mobile app launched in March 2023[3].
No clinical trial results are reported as this is not a therapeutic or drug development company.
The company’s technology aims to address unmet needs in underserved communities by providing access to tailored information for diverse hair types[2].
Their AI "Layla" connects users with brands and delivers actionable insights into their unique needs[1].
Key personnel include CEO Dr. Tiffany St. Bernard, who leads scientific development efforts[1][2].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HairDays.